Trisha Shetty

Michel Bouvier

Updated on
Share on FacebookTweet on TwitterShare on LinkedIn
Citizenship  Canadian
Field  Biochemistry
Michel Bouvier httpswwwiriccawordpresswpcontentuploads2
Born  September 14, 1958 (age 58) (1958-09-14)
Fields  Biochemistry and molecular pharmacology
Notable awards  Fellow of the Academy of Science of the Royal Society of Canada/ Fellow of the Canadian Academy of Health Sciences / Canada Research Chair in Signal Transduction and Molecular Pharmacology

Intervention du professeur michel bouvier les enjeux de la fiscalit partie 1


Michel Bouvier (born September 14, 1958) is a Canadian biochemist and molecular pharmacologist. He is a professor of biochemistry and molecular medicine at Université de Montréal; a principal investigator and the Chief Executive Officer at the Institute for Research in Immunology and Cancer; and an Associate Vice-President in Research, Scientific Discovery, Creation and Innovation at Université de Montréal. His work focuses on the study of cell signaling towards the discovery of new pharmaceutical drugs.

Contents

Intervention du professeur michel bouvier partie 2


Biography

Michel Bouvier earned a B.Sc. in Biochemistry (1979) and a Ph.D. in Neurological Sciences (1985) from Université de Montréal, and then completed a post-doctoral fellow (1985-1989) at Duke University under the supervision of Dr. Robert J. Lefkowitz (2012 Nobel Prize in Chemistry). Bouvier is a professor in the Department of Biochemistry and Molecular Medicine at the Faculty of Medicine of Université de Montréal and a principal investigator at the Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal.

Research

He is a world-known expert in cell signaling and drug discovery, notably in the field of G protein-coupled receptors (GPCRs). GPCRs constitute the largest single protein family involved in the transduction of hormonal signals and neurotransmitters. Their physiological significance makes them a prime target in drug development, and over a third of existing drugs use GPCRs as their target site of action. Bouvier’s work in the regulation of receptors led to new paradigms (inverse agonism; pharmacological chaperones; receptor polymerization; and pluri-dimensionality of signaling), which, coupled with the development of bioluminescence resonance energy transfer (BRET)-based methods, have a direct impact on drug discovery. He has authored over 260 scientific articles, filed 36 patent applications, and delivered over 400 lectures as a guest lecturer. Bouvier holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology

References

Michel Bouvier Wikipedia


Similar Topics
Tinnu Anand
Sarel Erwee
Goran Jezdimirović
Topics